

LIOM Day
We remove the biggest pain in health – the pain of not knowing
Today’s wearables track what you do and how you feel, but not the biochemistry that explains the why.
LIOM closes that gap: we’re building the ultimate health wearable for conscious living. It provides a continuous, needle-free window into your body’s chemistry, starting with glucose.
On 5th November 2026, we're opening our lab in Pfäffikon, Switzerland, to show you we've cracked it and are on schedule to launch our wearable in 2028.
We published our clinical results last year (doi: 10.1177/19322968251313811), demonstrating the science on our benchtop system. The open question since then has been the one that has defeated this field for thirty years: does it survive miniaturization?
On 5th November we will demonstrate that publicly for the first time. We will benchmark our miniaturized system — built entirely from components small enough to fit in a wearable — head-to-head against a benchtop system comparable to the one used in our clinical trials, live, in front of you. Compared with that benchtop system, the miniaturized version delivers:
300x smaller, sufficiently miniaturized for our wearable
12x higher light throughput, providing ample performance for our use case
1000x more throughput than any in its class size
Who you'll meet
LIOM Founder & CEO Leo Grünstein and his management team
Marc Maurer, former CEO of On Running and Board member
Jessie Inchauspé (aka Glucose Goddess), author of Glucose Revolution and Advisory Board member
Prof. Dr. Jürgen Popp, leading figure in clinical Raman spectroscopy and Advisory Board member
Prof. Dr. Lutz Heinemann, veteran of diabetes technology and clinical glucose measurement and Advisory Board member
Together, they'll speak to user needs and market opportunity and provide context on the technological progress LIOM has made towards realizing its vision.
This is an in-person event. Places are limited, so attendance is by application. Tell us a little about yourself and we'll be in touch with a decision.